COMMUNIQUÉS West-GlobeNewswire

Addex Trading Update in Accordance with Art. 53 of the SIX Listing Rules (Ad hoc publicity)
08/03/2019
Geneva, Switzerland, 8 March 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today an unaudited operating loss of CHF1.6 milion [...]
QIAGEN and Tecan announce collaboration to streamline preanalytical processing of QuantiFERON-TB Gold Plus
08/03/2019
Non-exclusive collaboration aims to accelerate adoption and ease of use in processing single-tube sample collection version of the market-leading modern blood test for latent TB detection Männedorf, Switzerland, and [...]
Helix BioPharma Corp.: First Patient Dosed in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin
07/03/2019
RICHMOND HILL, Ontario, March 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Chembio Diagnostics Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Issues 2019 Revenue Guidance MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported [...]
Immutep Presents Positive IMP761 Preclinical Results at 14th Congress of European Crohn’s and Colitis Organisation
07/03/2019
SYDNEY, Australia, March 07, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Zosano Pharma to Host Conference Call on Fourth Quarter and Full Year 2018 Financial Results and Provide Operational and Strategic Update
07/03/2019
FREMONT, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and webcast on Thursday, March [...]
Cue Biopharma to Host Business Update Call and Webcast
07/03/2019
CAMBRIDGE, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
LHC Group to Present at Two Healthcare Conferences in March
07/03/2019
LAFAYETTE, La., March 07, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that over the next two weeks the Company is presenting at the Barclays Global Healthcare Conference 2019 in Miami and at [...]
Tonix Pharmaceuticals Announces New European Use Patent for TNX-601
07/03/2019
Patent Expected to Provide Intellectual Property Protection until 2029 for Use of TNX-601 (Tianeptine Oxalate) for the Treatment of Neurocognitive Dysfunction Associated with Corticosteroids NEW YORK, March 07, 2019 ( [...]
INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results
07/03/2019
Strategic Transformation Building Momentum with Two Planned NDAs in 2019 PHOENIX, March 07, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and [...]
Cytokinetics Announces Presentation of Results From FORTITUDE-ALS at the American Academy of Neurology 71st Annual Meeting
07/03/2019
SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that results from FORTITUDE-ALS ( F unctional O utcomes in a R andomized T rial of I [...]
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
07/03/2019
BURLINGAME, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Calithera Biosciences Reports Fourth Quarter 2018 Financial Results and Recent Highlights
07/03/2019
-Calithera to Provide Corporate Update via Conference Call and Webcast at 1:30 p.m. PT on March 7, 2019 SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a [...]
Autolus Therapeutics to Host R&D Day on March 26, 2019
07/03/2019
Company to highlight next-generation, novel programmed T cell therapies in development for hematological and solid tumor indications Program and webcast to begin at 8:00 am ET LONDON, March 07, 2019 (GLOBE NEWSWIRE) -- [...]
HTG Molecular Diagnostics Reports Full Year 2018 Results
07/03/2019
Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG [...]
Integra LifeSciences to participate in Healthcare Conference in March 2019
07/03/2019
PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: [...]
Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, [...]
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
07/03/2019
Conference Call Scheduled for 4:30 p.m. ET today MENLO PARK, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended [...]
RTI Surgical® Shareholders Approve Paradigm Spine Acquisition
07/03/2019
ALACHUA, Fla., March 07, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced its shareholders have voted to approve completion of the company’s previously [...]

Pages